miR 1296-5p inhibits the migration and invasion of gastric cancer cells by repressing erbb2 expression

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Shan, Xia ^a   Wen, Wei ^b   Yan, Ting ^c   Cheng, Wenfang ^d   Huang, Zebo ^b   Zhang, Lan ^b   Zhang, Huo ^b   Wang, Tongshan ^b   Zhu, Wei ^b   Zhu, Yichao ^d   Zhu, Jun ^e  

^a THE AFFILIATED JIANGNING HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e JIANGSU CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MICRORNA; MICRORNA 1296 5P; RAC1 PROTEIN; TRASTUZUMAB; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ERBB2 PROTEIN, HUMAN; LUCIFERASE; MIRN-1296 MICRORNA, HUMAN; RAC1 PROTEIN, HUMAN;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GASTRIC CANCER CELL LINE; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE NEU; SIGNAL TRANSDUCTION; STOMACH CANCER; 3' UNTRANSLATED REGION; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REPORTER GENE; STOMACH; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; HUMANS; LUCIFERASES; LYMPHATIC METASTASIS; MICRORNAS; NEOPLASM INVASIVENESS; RAC1 GTP-BINDING PROTEIN; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; STOMACH; STOMACH NEOPLASMS;

EID: 85009952085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0170298     Document Type: Article

References (21)

1. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009; 374 (9688):477-90. doi: 10.1016/S0140-6736(09)60617-6 PMID: 19625077
2. Ishimoto T, Baba H, Izumi D, Sugihara H, Kurashige J, Iwatsuki M, et al. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation. Int J Cancer. 2016; 138 (6):1337-49. doi: 10.1002/ijc.29627 PMID: 26041092
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
4. Boo L, Ho WY, Ali NM, Yeap SK, Ky H, Chan KG, et al. MiRNA Transcriptome Profiling of Spheroid- Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line. Int J Biol Sci. 2016; 12(4):427-45. doi: 10.7150/ijbs.12777 PMID: 27019627
5. Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V, et al. Tumor suppressor role of micro- RNA-1296 in triple-negative breast cancer. Oncotarget. 2016.
6. Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, et al. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res. 2010; 70(7):2809-18. doi: 10.1158/0008-5472.CAN-09-4176 PMID: 20332239
7. Liu ZY, He WH, Gao JL, Luo JH, Huang X, Gao CF. Computational prediction and experimental validation of a novel synthesized pan-PIM inhibitor PI003 and its apoptosis-inducing mechanisms in cervical cancer. Oncotarget. 2015; 6(10):8019-35. doi: 10.18632/oncotarget.3139 PMID: 25749522
8. Fabi A, Mottolese M, Segatto O. Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinic. J Mol Med (Berl). 2014; 92(7):681-95. doi: 10. 1007/s00109-014-1169-7 PMID: 24861025
9. Yu D, Hung MC. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene. 2000; 19(53):6115-21. doi: 10.1038/sj.onc.1203972 PMID: 11156524
10. Verbeek BS, Adriaansen-Slot SS, Vroom TM, Beckers T, Rijksen G. Overexpression of EGFR and c- erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett. 1998; 425(1):145-50. PMID: 9541025
11. Bourguignon LY, Gilad E, Peyrollier K. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem. 2007; 282 (27):19426-41. doi: 10.1074/jbc.M610054200 PMID: 17493932
12. Zhou L, Jiang S, Fu Q, Smith K, Tu K, Li H, et al. FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration. Oncol Rep. 2016; 35(5):2715-22. doi: 10.3892/or.2016.4627 PMID: 26936618
13. Weissinger F, Reymond M, Dumke K, Kruger M. Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T). Onkologie. 2011; 34(10):548-51. doi: 10.1159/000332226 PMID: 21985855
14. Zurleni T, Gjoni E, Ballabio A, Casieri R, Ceriani P, Marzoli L, et al. Sixth and seventh tumor-nodemetastasis staging system compared in gastric cancer patients. World J Gastrointest Surg. 2013; 5 (11):287-93. doi: 10.4240/wjgs.v5.i11.287 PMID: 24520426
15. Zhao DS, Chen Y, Jiang H, Lu JP, Zhang G, Geng J, et al. Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure. Cardiovasc Pathol. 2013; 22(6):444-50. doi: 10.1016/j.carpath.2013.04.001 PMID: 23660476
16. Zhu Y, Shen T, Liu J, Zheng J, Zhang Y, Xu R, et al. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells. Cell Signal. 2013; 25(5):1075-85. doi: 10. 1016/j.cellsig.2013.01.015 PMID: 23353182
17. Liu J, Zhang Y, Xu R, Du J, Hu Z, Yang L, et al. PI3K/Akt-dependent phosphorylation of GSK3beta and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration. Cell Signal. 2013; 25(2):447- 56. doi: 10.1016/j.cellsig.2012.10.012 PMID: 23123500
18. Dong Z, Fu S, Xu X, Yang Y, Du L, Li W, et al. Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration. Br J Cancer. 2014; 110(7):1801-10. doi: 10. 1038/bjc.2014.70 PMID: 24548863
19. Wang SE, Shin I, Wu FY, Friedman DB, Arteaga CL. HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta. Cancer Res. 2006; 66(19):9591- 600. doi: 10.1158/0008-5472.CAN-06-2071 PMID: 17018616 20.
20. Johnson E, Seachrist DD, DeLeon-Rodriguez CM, Lozada KL, Miedler J, Abdul-Karim FW, et al. HER2/ ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J Biol Chem. 2010; 285(38):29491-501. doi: 10.1074/jbc.M110.136770 PMID: 20595387
21. Tornillo G, Bisaro B, Camacho-Leal Mdel P, Galie M, Provero P, Di Stefano P, et al. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1. Eur J Cell Biol. 2011; 90(2-3):237-48. doi: 10.1016/j.ejcb.2010.09. 002 PMID: 20961652